EMG – initiated electro – stimulation is used success – fully in the rehabilitation of patients with paralyses of the extremities following central lesions such as:
Mentamove is based on modern knowledge and experience of neuroplasticity. The ability of the central nervous system to reorganize its function, to “recover” and to “re-learn” is amazing great, especially if it is given the necessary support during rehabilitation.
Why Mentamove? Mentamove is effective without side effects, very user-friendly and is optimum for use in the patient’s home: self-explanatory user guidance over display, automatic microchip controlled customization and storage of the exercise parameters, simple electrode plant.
Mentamove is used successfully in clinics and therapy practices as an additive treatment and if employed systematically it can be a direct route to improve the rehabilitant’s quality of life. Mentamove is competitive and economical. Its “primary benefit” lies in a general improvement of the patient’s state of health and contentment to be able to use social contacts again and to carry out everyday activities again.
Its “secondary benefit” should be seen in a reduction of illness costs and decrease in medications, e.g. analgesics or antispasmodics or barbiturates. Also other aids like wheelchair, rollator or peroneus – splints are often no longer necessary. The consequences of a permanents need for nursing can also be minimized. Individual treatment with Mentamove is intended to create the optimum utilization of needs for doctor and patient.
Mentamove can be used effectively immediately after the event as well as years thereafter.
Mentamove should not be used by patients with heart pacemakers or during pregnancy. Please ask the doctor if risks are present!
With exercising with Mentamove, neural stimulation electrodes are placed on the skin surface above the muscle responsible for the joint movement. The patient directs his full attention to carrying out a deliberate, motivating, complex movement (intention) and carries out the movement only in his imagination. He exercises in his mind.
Mentamove records the potential change generated in the target muscle and, when it reaches an individual marginal value, it converts into the intend activity. Reward for the patient => a visible movement is carried out. The voluntary motor control loop is closed via the time – linked feedback of the movement to the CNS (Central Nervous System) (efference – afference coupling and the motor learning processes are encouraged and supported.
Mentamove uses amplitude modulated medium – frequency sin- wave current. The patient fells the electrical pulse as a pleasant “soft” stimulation. The storage of data in Mentamove enables up-to date, immediate and long-term recall of the exercise parameters on the display.
Mentamove is a German product. It was developed jointly by plfR in Karlsfeld/Munich and K.I.D. – Systems GmnH in Buxtehude, a subsidiary of the Daimler-Chrysler Aerospace Airbus GmbH Company (DASA) and is manufactured to the highest quality standards of aerospace technology.
Crisan R. & Gerner Ch.2000, the effectiveness of EMG-initiated electro stimulation in patients who had suffered a stroke more than 1 year previously. Neurological & Geriatric Rehabilitation Clinic, Rottal Foundation, Bad Briesbach. Germany.